Skip to main content

Table 1 Baseline characteristics (n = 94)

From: Serum CGRP in migraine patients using erenumab as preventive treatment

Characteristic
Women, n (%) 79 (84)
Age, mean ± SD (years) 42 ± 12.6
Migraine without aura, n (%) 60 (64)
Episodic migraine, n (%) 52 (55)
MMD baseline, mean ± SD 13.7 ± 5.7
MHD baseline, mean ± SD 16.5 ± 6.1
Failed prophylactics, mean ± SD 5.0 ± 1.0
  1. MMD monthly migraine days, MHD monthly headache days, A month is defined as 28 days. Baseline = 28 days before starting treatment